[1]朱素君,谢锦桃,刘军,等.二甲双胍:2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280-282.
点击复制

二甲双胍:2型糖尿病治疗的基础药
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2007年04期
页码:
280-282
栏目:
药物研究
出版日期:
2007-08-20

文章信息/Info

作者:
朱素君;谢锦桃;刘军;任宝江;杨重浙;江婕;蒋妮;
深圳市妇幼保健院;深圳市中联制药市场医学部;
关键词:
2型糖尿病治疗二甲双胍
摘要:
糖尿病是一种临床常见多发的慢性代谢疾病,严重危害着人类健康与生命。糖尿病的药物治疗对控制血糖和延缓并发症发生十分重要,其中二甲双胍在2型糖尿病药物治疗中具有基石地位。

相似文献/References:

[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.007]
 Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(04):31.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.007]
[3]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.008]
 Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(04):35.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.008]
[4]张红 章向成 朱大龙.炎性反应与糖尿病肾病[J].国际内分泌代谢杂志,2015,(01):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
 Zhang Hong*,Zhang Xiangcheng,Zhu Dalong..Role of inflammation in diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):49.[doi:10.3760/cma.j.issn.1673-4157.2015.01.012]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
 Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(04):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
 Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
 Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(04):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]许莉军,姜艳,夏维波.低磷酸酶血症的研究进展[J].国际内分泌代谢杂志,2015,(03):211.[doi:10.3760/cma.j.issn.1673-4157.2015.03.020]
 Xu Lijun,Jiang Yan,Xia Weibo..Research progress of hypophosphatasia[J].International Journal of Endocrinology and Metabolism,2015,(04):211.[doi:10.3760/cma.j.issn.1673-4157.2015.03.020]
[9]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
 Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[10]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
 Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[11]李春睿,徐书杭,蔡可英,等.限食疗法对2型糖尿病的预防和治疗作用[J].国际内分泌代谢杂志,2014,(02):123.[doi:10.3760/cma.j.issn.1673-4157.2014.02.015]
 Li Chunrui*,Xu Shuhang,Cai Keying,et al.Preventive and therapeutic effects of caloric restriction therapy on type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2014,(04):123.[doi:10.3760/cma.j.issn.1673-4157.2014.02.015]

更新日期/Last Update: 2007-08-20